Drug Database
Back to search

Belgium· BE-AMP-SAM239346-00

Remergon Soltab 15 mg

A mirtazapine product containing mirtazapine, registered in Belgium by Organon Belgium. The same ATC class is registered in 18 of our 19 countries.

ATC N06AX11

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedRemergon Soltab 15 mgATCN06AX11REGISTER NO.BE-AMP-SAM239346-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mirtazapineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mirtazapine is registered in 18 of 19 countries.

Countries holding a registration under ATC N06AX11 (mirtazapine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 11 of them publish a price we can compare per daily dose
Search mirtazapine products by name

Mirtazapine · ATC N06AX11

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mirtazapine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.22 in France to $1.40 in Switzerland — a ×6.4 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Mirtazapine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.40
  • IT Italy$0.61
  • FR France$0.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Mirtazapine
Manufacturer
Organon Belgium
Country
Belgium (BE)
ATC code
N06AX11
ATC class
Mirtazapine
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    1766393
    EUR 12.72
  • be_apb
    0773408

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

482 interactions on record for mirtazapine.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check mirtazapine against other medicinesHow interaction checks work

Mirtazapine · interactions on record

482 records

  • 50 severe
  • 234 moderate
  • 2 minor
  • 162 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

34 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N06AX11

Mirtazapine, as other registers publish it.

All mirtazapine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e2a95884-e02b-46e5-9925-40ac63fa956e
GET /v1/drugs/e2a95884-e02b-46e5-9925-40ac63fa956e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Orodispersible tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Remergon Soltab 15 mg",
  "name_fr": "Remergon Soltab 15 mg",
  "name_nl": "Remergon Soltab 15 mg",
  "amp_code": "SAM239346-00",
  "strengths": [
    "15.0000",
    "80.9100",
    "121.3300",
    "8.9900",
    "4.6500"
  ],
  "pack_count": 7,
  "substances": [
    "Mirtazapine",
    "Mannitol",
    "Sodium Hydrogen Carbonate",
    "Aspartame",
    "Sugar Spheres"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Mirtazapine",
  "authorisation_numbers": [
    "BE239346"
  ]
}
API referenceMCP serverPlans

See everything about mirtazapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console